CCTN - CONTRACEPTIVE CLINICAL TRIALS - MALE SITES, NES/TES STUDY
$332,945N03FY2014HDNIH
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center, Torrance CA
Investigators
Abstract
Evaluate suppression of gonadotrophins in response to Nestorone and Testosterone gel compared to Testosterone gel. CENTRAL LABORATORY FOR THE STUDY ON THE 28 DAYS REPEAT-DOSE SAFETY AND TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS STUDY OF COMBINED NESTORONE/TESTOSTERONE GEL IN HEALTHY MEN The objective of this Task Order is to obtain valid and reliable data for the effect of Testosterone Gel and of a combination ofNestorone® and Testosterone Gel on serum hormone levels.
View original record on NIH RePORTER →